PBIO company redesigned its UST Technology Platform to be used in the CBD beverage industry. This new technology called the BaroShear K45 has been specifically designed to meet all of the specifications required for the efficient processing of CBD oil into a completely water soluble end product to be used in the CBD infused beverage industry. The BaroShear K45 is a unique and powerful next generation nanoemulsification system that uses the company's UST Ultra Sheer Technology Platform to process CBD oil in a cost effective manner without the use of harmful and expensive chemicals. This scientific breakthrough will be marketed to CBD infused beverage companies and CBD oil processing companies located around the globe. The company already has worldwide sales and distribution channels in place to market and service the BaroShear K45. The company has put collaboration agreements together with several CBD industry veterans leading to strategic partnership opportunities that further benefit the company's research and development efforts. The company's superior CBD end product gives the company a huge branding opportunity that can possibly lead to very substantial contracts and joint venture licensing deals.
The company's BaroShear K45 product launch couldn't have come at a more opportune time in the CBD industry's history. With the passage of the 2018 Farm Bill, entrepreneurs are rushing to grow hemp and extract CBD oil that is water soluble and safe for sale to individual consumers or as an ingredient that is infused into beverages. Projected revenue for CBD infused beverages alone is expected to be $220 million by 2022.
The company recently projected this years revenue to double from $2.5 million to $5 million as a result of the high demand expected for the company's BaroShear K45 technology. Technology companies with 100% growth rates can easily trade at upwards of 10 times annual sales which could realistically lead to a $50 million valuation for the company's stock. With less than 2 million shares outstanding the stock may move significantly higher from current levels in the near term as the current market capitalization is a miniscule $5.9 million offering a substantial upside to the company's shares. Trading at only 1.2 times this years forecasted sales PBIO is a very cheap stock compared with its CBD industry peers. The company previously traded on the NASDAQ for upwards of $18.00. The CBD market is hot and valuations are soaring. PBIO is a great way to add the extraordinary growth of the CBD sector to your portfolio.
The company's BaroShear K45 product launch couldn't have come at a more opportune time in the CBD industry's history. With the passage of the 2018 Farm Bill, entrepreneurs are rushing to grow hemp and extract CBD oil that is water soluble and safe for sale to individual consumers or as an ingredient that is infused into beverages. Projected revenue for CBD infused beverages alone is expected to be $220 million by 2022.
The company recently projected this years revenue to double from $2.5 million to $5 million as a result of the high demand expected for the company's BaroShear K45 technology. Technology companies with 100% growth rates can easily trade at upwards of 10 times annual sales which could realistically lead to a $50 million valuation for the company's stock. With less than 2 million shares outstanding the stock may move significantly higher from current levels in the near term as the current market capitalization is a miniscule $5.9 million offering a substantial upside to the company's shares. Trading at only 1.2 times this years forecasted sales PBIO is a very cheap stock compared with its CBD industry peers. The company previously traded on the NASDAQ for upwards of $18.00. The CBD market is hot and valuations are soaring. PBIO is a great way to add the extraordinary growth of the CBD sector to your portfolio.
